Download presentation
Presentation is loading. Please wait.
Published byEvelyn Wilkins Modified over 5 years ago
1
A Phase II Study of Carboplatin, Etoposide, and Exisulind in Patients with Extensive Small Cell Lung Cancer: CALGB 30104 Ramaswamy Govindan, MD, Xiaofei Wang, PhD, Maria Q. Baggstrom, MD, Susan Burdette-Radoux, MD, Lydia Hodgson, MS, Everett E. Vokes, MD, Mark R. Green, MD Journal of Thoracic Oncology Volume 4, Issue 2, Pages (February 2009) DOI: /JTO.0b013e eb0 Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions
2
FIGURE 1 Kaplan-Meier curve of the overall survival for 44 patients who received the combination treatment. Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e eb0) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions
3
FIGURE 2 Kaplan-Meier curve of the failure free survival for 44 patients who received the combination treatment. Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e eb0) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.